N-(2-(4-Ethylphenylamino)benzo[d]oxazol-5-yl)-3,4,5-trimethoxybenzamide

ID: ALA4075716

Chembl Id: CHEMBL4075716

PubChem CID: 54765795

Max Phase: Preclinical

Molecular Formula: C25H25N3O5

Molecular Weight: 447.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1ccc(Nc2nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3o2)cc1

Standard InChI:  InChI=1S/C25H25N3O5/c1-5-15-6-8-17(9-7-15)27-25-28-19-14-18(10-11-20(19)33-25)26-24(29)16-12-21(30-2)23(32-4)22(13-16)31-3/h6-14H,5H2,1-4H3,(H,26,29)(H,27,28)

Standard InChI Key:  YPAFQRWXJVUJNK-UHFFFAOYSA-N

Associated Targets(Human)

IL6 Tclin Interleukin-6 (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 447.49Molecular Weight (Monoisotopic): 447.1794AlogP: 5.41#Rotatable Bonds: 8
Polar Surface Area: 94.85Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.30CX Basic pKa: CX LogP: 5.02CX LogD: 5.02
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.37Np Likeness Score: -1.10

References

1. Kim D, Won HY, Hwang ES, Kim YK, Choo HP..  (2017)  Synthesis of benzoxazole derivatives as interleukin-6 antagonists.,  25  (12): [PMID:28442260] [10.1016/j.bmc.2017.03.072]

Source